Testing effectiveness (Phase 2)Study completedNCT01527513
What this trial is testing
Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures
Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 123